Serum lipid profiles among patients initiating ritonavir-boosted atazanavir versus efavirenz-based regimens

BACKGROUND: Antiretrovirals used to treat HIV-infected patients have the potential to adversely affect serum lipid profiles and increase the risk of cardiovascular disease which is an emerging concern among HIV-infected patients. Since boosted atazanavir and efavirenz are both considered preferred a...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Ganesan, Anuradha, Benning, Lorie, Golub, Elizabeth T, Riddle, Mark, Crum-Cianflone, Nancy, Tasker, Sybil, Jacobson, Lisa, Gange, Stephen J
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2009
Предметы:
Short Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2712469/
https://ncbi.nlm.nih.gov/pubmed/19545433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-6405-6-13
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы